Ceftazidime-Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region

Sadeleştirilmiş öğe sayfası
dc.contributor.authorDumlu, Ridvan
dc.contributor.authorSahin, Meyha
dc.contributor.authorDerin, Okan
dc.contributor.authorGul, Ozlem
dc.contributor.authorBasgonul, Sedef
dc.contributor.authorZengin, Rehile
dc.contributor.authorArabaci, Cigdem
dc.contributor.authorSimsek, Funda
dc.contributor.authorGencer, Serap
dc.contributor.authorKocagoz, Ayse Sesin
dc.contributor.authorMert, Ali
dc.date.accessioned2025-10-16T15:12:38Z
dc.date.issued2024
dc.identifier.doi10.3390/antibiotics13100990
dc.identifier.otherWOS:001343716900001
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5536
dc.publisherMDPI
dc.sourceANTIBIOTICS-BASEL
dc.subjectceftazidime\\-avibactam
dc.subjectpolymyxins
dc.subjectOXA\\-48
dc.subjectcarbapenem\\-resistant enterobacterales
dc.subjectblood stream infections
dc.subjectmortality
dc.titleCeftazidime-Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS